Mumbai: In a move set to redefine AI innovation in life sciences, ThinkBio Ai, a leading provider of AI-powered solutions for biopharmaceutical and healthcare organizations, has partnered with UST, a global digital transformation company.
This collaboration is designed to deliver cutting-edge AI-enabled platforms that streamline R&D, drive innovation, and improve patient outcomes across the biopharma and healthcare landscape.
Through this strategic alliance, UST will integrate its digital transformation and generative AI capabilities with ThinkBio Ai’s suite of advanced solutions.
These tools, developed by domain experts in oncology, immunology, neurology, and cardiology, are designed to solve key challenges in preclinical and clinical R&D pipelines – including drug repurposing, biomarker-driven patient stratification, and clinical trial optimization using digital twin technology.
ThinkBio AI: AI-enhanced Research Co-Pilot (R-COP)
A core offering from ThinkBio Ai is the AI-enhanced Research Co-Pilot (R-COP), a next-generation tool that enhances existing Laboratory Information Management Systems (LIMS) and transforms routine research processes into insight-led, high-performance operations. R-COP integrates seamlessly with existing infrastructure, ensuring scalable and impactful AI adoption for life sciences organizations.
The partnership will also leverage ThinkBio Ai’s proprietary BioThinkHub data platform, which synthesizes expertly curated biological and clinical data from both public and private sources to power real-time decision-making in research environments.
Also Read: Trust AI Raises USD 6 Million to Build Operating System for Future of Dentistry
“This partnership brings our AI-driven R&D transformation solutions into UST’s digital innovation ecosystem, enabling tailored solutions for life sciences enterprises,” said Pradeep Palazhi, Founder and CEO of ThinkBio Ai.
“Together, we will help clients navigate a dynamic regulatory landscape and unlock measurable value through AI,” added Anu Koshy, Life Sciences Cluster Leader, UST.
The collaboration aims to empower pharmaceutical, biotech, and medical device companies with scalable, intelligent ecosystems that reduce time-to-value, boost clinical success, and foster competitive advantage in a highly regulated industry.
